Topic > Diabetes Research Paper Notes - 2492

Article No. 1: Prevalence/Incidence Global Diabetes Prevalence Estimates for 2010 and 2030 Diabetes is a disease that continues to increase worldwide. It continues to be a major problem in both developed and underdeveloped countries. This article summarizes a study focusing on the estimated future number of people diagnosed with diabetes from 2010 to 2030. The findings were that the amount of people diagnosed with the disease will increase worldwide by approximately 1% (with an increase of approximately 200 million more adults diagnosed between the ages of 20 and 79). It doesn't seem like much, but the number of people diagnosed with diabetes in underdeveloped countries would increase by about 69% by 2030, and the number of people diagnosed in developed countries would increase by about 20% by 2030. This article demonstrates that the problem of diabetes isn't going away anytime soon. It is a growing epidemic that continues to affect millions of people around the world. I think more and more people need to be educated about diabetes and the personal lifestyle choices that impact their health so immensely. I know it's easier said than done, but knowledge is power. And in this case, the more knowledge people have about diabetes and diabetes prevention, the more the number of people diagnosed with the disease will decrease.Article #2: TreatmentLiraglutide: effects beyond glycemic control in the treatment of diabetesL The article expresses the correlation between obesity and patients with type 2 diabetes and how the GLP-1 receptor, Liraglutide, can stimulate weight loss in these obese patients. Due to their high levels of insulin resistance, obese individuals are more likely to be diagnosed with type 2 diabetes. After performing clinical studies on patients diagnosed with type 2 diabetes, Liraglutide was found to stimulate weight loss and increases beta cell function. Scientists believe that Liraglutide can reduce the number of patients diagnosed with type 2 diabetes and prevent cardiovascular disease. I found this article very interesting. I knew that obesity played an important role in the diagnosis of type 2 diabetes, but I didn't know the extent to which scientists are trying to reduce obesity through certain hormone injections. I think the growing obese population in the United States should adopt an overall healthier lifestyle before having to resort to hormone injections to lose weight. Although the use of Liraglutide can reduce both type 2 diabetes and cardiovascular disease, so can a healthy lifestyle.